1. The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets.
- Author
-
Gopinath P, Natarajan A, Sathyanarayanan A, Veluswami S, and Gopisetty G
- Subjects
- Cell Adhesion Molecules physiology, Extracellular Matrix Proteins analysis, Humans, Matrix Metalloproteinases physiology, Osteonectin analysis, Osteonectin physiology, Osteopontin physiology, Tenascin physiology, Thrombospondin 1 physiology, Treatment Outcome, Biomarkers, Tumor, Extracellular Matrix Proteins physiology, Neoplasms etiology, Neoplasms therapy
- Abstract
The extracellular matrix (ECM) is composed of a mesh of proteins, proteoglycans, growth factors, and other secretory components. It constitutes the tumor microenvironment along with the endothelial cells, cancer-associated fibroblasts, adipocytes, and immune cells. The proteins of ECM can be functionally classified as adhesive proteins and matricellular proteins (MCP). In the tumor milieu, the ECM plays a major role in tumorigenesis and therapeutic resistance. The current review encompasses thrombospondins, osteonectin, osteopontin, tenascin C, periostin, the CCN family, laminin, biglycan, decorin, mimecan, and galectins. The matrix metalloproteinases (MMPs) are also discussed as they are an integral part of the ECM with versatile functions in the tumor stroma. In this review, the role of these proteins in tumor initiation, growth, invasion and metastasis have been highlighted, with emphasis on their contribution to tumor therapeutic resistance. Further, their potential as biomarkers and therapeutic targets based on existing evidence are discussed. Owing to the recent advancements in protein targeting, the possibility of agents to modulate MCPs in cancer as therapeutic options are discussed., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF